Patent · US Active

Compositions and methods for modulating Factor VIII function

US12252528B2 · kind B2 · utility

0Cited by
4References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2019
Grant dateMar 18, 2025
Priority date—
Expiry dateApr 4, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Factor VIII variants and methods of use thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.